Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
Clinical trial NCT04551963 · COMPLETED
Trial details
- NCT number
- NCT04551963
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-15
- Primary completion
- 2022-02-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.